| Dapagliflozin in patients recently hospitalized with heart failure and mildly reduced or preserved ejection fraction JW Cunningham, M Vaduganathan, BL Claggett, IJ Kulac, AS Desai, ... Journal of the American College of Cardiology 80 (14), 1302-1310, 2022 | 65 | 2022 |
| Efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction according to age: the DELIVER trial A Peikert, FA Martinez, M Vaduganathan, BL Claggett, IJ Kulac, AS Desai, ... Circulation: Heart Failure 15 (10), e010080, 2022 | 52 | 2022 |
| Effect of dapagliflozin on health status in patients with preserved or mildly reduced ejection fraction MN Kosiborod, AS Bhatt, BL Claggett, M Vaduganathan, IJ Kulac, ... Journal of the American College of Cardiology 81 (5), 460-473, 2023 | 36 | 2023 |
| Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF M Vaduganathan, RJ Mentz, BL Claggett, ZM Miao, IJ Kulac, JH Ward, ... European Heart Journal 44 (31), 2982-2993, 2023 | 31 | 2023 |
| Sex differences in characteristics, outcomes, and treatment response with dapagliflozin across the range of ejection fraction in patients with heart failure: insights from DAPA … X Wang, M Vaduganathan, BL Claggett, SM Hegde, M Pabon, IJ Kulac, ... Circulation 147 (8), 624-634, 2023 | 23 | 2023 |
| The effects of dapagliflozin on symptoms, function and quality of life in patients with heart failure and mildly reduced or preserved ejection fraction: results from the … MN Kosiborod, A Bhatt, B Claggett, M Vaduganathan, I Kulac, CS Lam, ... CIRCULATION 146 (25), E596-E597, 2022 | 10 | 2022 |
| Effect of dapagliflozin on health status and quality of life across the spectrum of ejection fraction: Participant‐level pooled analysis from the DAPA‐HF and DELIVER trials AS Bhatt, MN Kosiborod, M Vaduganathan, BL Claggett, ZM Miao, ... European Journal of Heart Failure 25 (7), 981-988, 2023 | 8 | 2023 |
| Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction according to polypharmacy status A Peikert, P Goyal, M Vaduganathan, BL Claggett, IJ Kulac, ZM Miao, ... Heart Failure 11 (10), 1380-1393, 2023 | 7 | 2023 |
| Contemporary use and implications of beta-blockers in patients with HFmrEF or HFpEF: the DELIVER trial A Peikert, BA Bart, M Vaduganathan, BL Claggett, IJ Kulac, MN Kosiborod, ... Heart Failure 12 (4), 631-644, 2024 | 4 | 2024 |
| Effect of Eplontersen on Cardiac Structure and Function in Patients With Hereditary Transthyretin Amyloidosis A Masri, MS Maurer, BL Claggett, I Kulac, MW Cruz, I Conceição, ... Journal of Cardiac Failure, 2023 | 2 | 2023 |
| Changes in mid‐regional pro‐adrenomedullin during treatment with sacubitril/valsartan PL Myhre, Y Liu, IJ Kulac, BL Claggett, MF Prescott, GM Felker, J Butler, ... European Journal of Heart Failure 25 (8), 1396-1405, 2023 | 2 | 2023 |
| Generalizability of the Spectrum of Kidney Risk in the FINEARTS-HF Trial to US Adults with Heart Failure JW Ostrominski, R Aggarwal, BL Claggett, IJ Kulac, AS Desai, PS Jhund, ... Journal of Cardiac Failure, 2024 | | 2024 |
| ABDOMINAL OBESITY AND OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: THE PARAGON-HF TRIAL A Peikert, M Vaduganathan, B Claggett, I Kulac, SE Litwin, MR Zile, ... Journal of the American College of Cardiology 83 (13_Supplement), 361-361, 2024 | | 2024 |
| DAPAGLIFLOZIN IN PATIENTS WITH HEART FAILURE ACROSS A RANGE OF LEFT VENTRICULAR HYPERTROPHY IN THE DELIVER TRIAL M Vaduganathan, B Claggett, I Kulac, ND Johansen, N Reza, PS Jhund, ... Journal of the American College of Cardiology 83 (13_Supplement), 320-320, 2024 | | 2024 |
| Dapagliflozin in patients with heart failure and previous myocardial infarction: A participant‐level pooled analysis of DAPA‐HF and DELIVER A Peikert, M Vaduganathan, BL Claggett, IJ Kulac, A Foà, AS Desai, ... European Journal of Heart Failure, 2024 | | 2024 |
| Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the … AS Bhatt, M Vaduganathan, BL Claggett, IJ Kulac, IS Anand, AS Desai, ... Journal of the American Heart Association, e032279, 2024 | | 2024 |
| Efficacy and Safety of Dapagliflozin in Patients With Heart Failure and Previous Myocardial Infarction A Peikert, M Vaduganathan, BL Claggett, IJ Kulac, A Foà, AS Desai, ... Circulation 148 (Suppl_1), A18437-A18437, 2023 | | 2023 |
| Sex Differences in Characteristics, Outcomes and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure CS Lam, X Wang, M Vaduganathan, BL Claggett, SL Hegde, IJ Kulac, ... CIRCULATION 146 (25), E597-E598, 2022 | | 2022 |
